153 related articles for article (PubMed ID: 1673786)
21. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
[TBL] [Abstract][Full Text] [Related]
22. Role of protective drugs in the prevention of ulcer relapse.
Ota S; Terano A
J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
[TBL] [Abstract][Full Text] [Related]
23. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
Fallone CA; Loo V; Joseph L; Barkun J; Kostyk R; Barkun AN
Clin Invest Med; 1999 Oct; 22(5):185-94. PubMed ID: 10579057
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori].
Lamouliatte H
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S58-S63. PubMed ID: 8734372
[No Abstract] [Full Text] [Related]
25. H2 receptor antagonist or H. pylori eradication?
Ahmed W; Qureshi H; Syed S; Alam E; Zuberi SJ
J Pak Med Assoc; 1992 Apr; 42(4):81-2. PubMed ID: 1350800
[TBL] [Abstract][Full Text] [Related]
26. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G
Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995
[TBL] [Abstract][Full Text] [Related]
27. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
28. Sucralfate in Helicobacter pylori eradication strategies.
Lam SK; Hu WH; Ching CK
Scand J Gastroenterol Suppl; 1995; 210():89-91. PubMed ID: 8578217
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of ulcer recurrence after vagotomy of oxyntic cells with sucralfate].
Fernández Dovale M; Docobo Durántez F; Lozano Crivell M
Rev Esp Enferm Dig; 1990 Feb; 77(2):109-12. PubMed ID: 2346677
[TBL] [Abstract][Full Text] [Related]
30. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
[TBL] [Abstract][Full Text] [Related]
32. Maintenance therapy with sucralfate in duodenal ulcer: genuine prevention or accelerated healing of ulcer recurrence?
Bynum TE; Koch GG
Am J Med; 1991 Aug; 91(2A):84S-90S. PubMed ID: 1882909
[TBL] [Abstract][Full Text] [Related]
33. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
J Formos Med Assoc; 1993 Aug; 92(8):721-4. PubMed ID: 7904847
[TBL] [Abstract][Full Text] [Related]
34. Site-and cytoprotective drugs in the short-term treatment of peptic ulcer. What is their current role?
Bianchi Porro G; Parente F
Ital J Gastroenterol; 1990; 22 Suppl 1():5-10. PubMed ID: 1983422
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic approach to ulcer healing.
Blum AL
Am J Med; 1985 Aug; 79(2C):8-14. PubMed ID: 2863981
[TBL] [Abstract][Full Text] [Related]
36. Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study.
Huang CK; Chen GH
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):15-20. PubMed ID: 8364776
[TBL] [Abstract][Full Text] [Related]
37. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
[TBL] [Abstract][Full Text] [Related]
38. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
Miller JP; Faragher EB
Scand J Gastroenterol Suppl; 1989; 160():39-45. PubMed ID: 2573145
[TBL] [Abstract][Full Text] [Related]
39. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
40. Eradication of Campylobacter pylori and recurrence of duodenal ulcer. A six-month follow-up study.
Mouzas IA; Kalantzis N; Gabriel P; Kallimanis G; Papantoniou P; Mavrogiannis H
Acta Gastroenterol Latinoam; 1990; 20(3):159-61. PubMed ID: 2095099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
